Bank of Nova Scotia’s Kindred Healthcare KND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-72,829
Closed -$666K 995
2018
Q1
$666K Sell
72,829
-263,000
-78% -$2.43M ﹤0.01% 780
2017
Q4
$3.26M Sell
335,829
-569,588
-63% -$4.24M 0.01% 487
2017
Q3
$6.16M Buy
905,417
+29,100
+3% +$248K 0.04% 332
2017
Q2
$10.2M Buy
876,317
+612,598
+232% +$6.04M 0.05% 285
2017
Q1
$2.2M Buy
263,719
+166,000
+170% +$1.3M 0.01% 606
2016
Q4
$767K Buy
+97,719
New +$802K ﹤0.01% 528

Other funds holding KND

Bank of Nova Scotia's KND Position: Q2 2018 in Review

Bank of Nova Scotia sold out of Kindred Healthcare (KND) in Q2 2018, closing a stake of 72,829 shares — an estimated $666K sold.

Bank of Nova Scotia first reported a position in KND in Q4 2016 and held it in 6 quarters. The position peaked at $10.2M in Q2 2017. 149 funds tracked by Wall St. Rank hold KND as of Q2 2018.

  • Bank of Nova Scotia reported no remaining Kindred Healthcare position as of Q2 2018 after selling out during the quarter.
  • Bank of Nova Scotia sold 72,829 Kindred Healthcare shares in Q2 2018, an estimated $666K.
  • Bank of Nova Scotia first reported a position in Kindred Healthcare in Q4 2016 and held it in 6 quarters.
  • Bank of Nova Scotia's Kindred Healthcare position peaked at $10.2M in Q2 2017.
  • 149 funds tracked by Wall St. Rank held Kindred Healthcare as of Q2 2018.

Based on Bank of Nova Scotia's 13F filing for Q2 2018, filed 14 Aug 2018.